Showing results (261-270 of 824) with videos related to
Sort By:
Pageof 83
Hematology/Oncology Clinics of North America|November 13, 2007
Mouse models of human myelomaConstantine S Mitsiades, Kenneth C Anderson, Daniel R CarrascoFrontiers in Immunology|August 28, 2018
Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based ImmunotherapyShih-Feng Cho, Kenneth C Anderson, Yu-Tzu TaiBlood Reviews|August 7, 2002
Novel therapies for multiple myelomaJoan J Ryoo, Craig Emmitt Cole, Kenneth C AndersonFrontiers in Immunology|August 28, 2018
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1Yu-Tzu Tai, Shih-Feng Cho, Kenneth C AndersonLancet (London, England)|July 8, 2026
Systemic light chain and transthyretin amyloidosis-treatment advancements and future directionsGiada Bianchi, Vaishali Sanchorawala, Ashutosh Wechalekar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2016
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation StatusMichele Cea, Antonia Cagnetta, Chirag Acharya, et al.Blood|December 18, 2015
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cellsMichele Cea, Antonia Cagnetta, Sophia Adamia, et al.Blood|October 20, 2005
Antimyeloma activity of heat shock protein-90 inhibitionConstantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.Science Advances|June 5, 2021
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironmentJiye Liu, Teru Hideshima, Lijie Xing, et al.Clinical Lymphoma, Myeloma & Leukemia|July 12, 2020
Role of the Bone Marrow Milieu in Multiple Myeloma Progression and Therapeutic ResistanceMatthew Ho, Chia Yin Goh, Ashish Patel, et al.Pageof 83